FindTrial
Sign In

Chronic Kidney Disease Associated Pruritis (CKDaP)

Prevalence And Influencing Factors Of Chronic Kidney Disease Associated Pruritis (CKDaP) And Its Impact On Quality Of Life And Sleep - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060247
Enrollment
100
Registered
2023-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N185- Chronic kidney disease, stage 5

Interventions

Intervention1: Nil: Nil

Sponsors

Kasturba Medical Hospital Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: On Hemodialysis for more than three months

Exclusion criteria

Exclusion criteria: Patients on peritoneal dialysis. Skin diseases other than uremic pruritus. AKI patients.

Design outcomes

Primary

MeasureTime frame
Primary outcome: Prevalence of uremic pruritus in maintenance hemodialysis patients. Analyzing the factors influencing CKDaP in maintenance hemodialysis patients. Timepoint: 1 year (from December 2023 to December 2024)—

Secondary

MeasureTime frame
The intensity, impact on health related quality of life & sleep will be assessed using Pruritus Severity Scale, 5D Itch Scale, and SKINDEX 16 & PSQI questionnaire, respectively. Data will be analyzed.Timepoint: 1 year (from December 2023 to December 2024)—

Countries

India

Contacts

Public ContactShreya Jain

Kasturba Medical College, Manipal Academy of Higher Education

mohan.vb@manipal.edu09902548725

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026